Correlation Between HCW Biologics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Lyra Therapeutics, you can compare the effects of market volatilities on HCW Biologics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Lyra Therapeutics.
Diversification Opportunities for HCW Biologics and Lyra Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between HCW and Lyra is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between HCW Biologics and Lyra Therapeutics
Given the investment horizon of 90 days HCW Biologics is expected to generate 7.21 times more return on investment than Lyra Therapeutics. However, HCW Biologics is 7.21 times more volatile than Lyra Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 54.00 in HCW Biologics on August 29, 2024 and sell it today you would earn a total of 2.00 from holding HCW Biologics or generate 3.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Lyra Therapeutics
Performance |
| Timeline |
| HCW Biologics |
| Lyra Therapeutics |
HCW Biologics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Lyra Therapeutics
The main advantage of trading using opposite HCW Biologics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |